MedPath

Comparison of the effectiveness of 2 cervical ripening agents Oral Mifepristone and vaginal Isosorbide Mononitrate (IMN) for induction of labor in pregnant women with gestational age 28 to 34 weeks.

Phase 2
Conditions
Health Condition 1: O619- Failed induction of labor, unspecified
Registration Number
CTRI/2023/06/053401
Lead Sponsor
Dr Meeta Pandit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All 28 to 34 weeks pregnancy who need Induction of labor for obstetrics and maternal indications.

2.Bishops score less than 4.

3.Those giving consent.

Exclusion Criteria

1.Contraindications to vaginal birth.

2.Hypersensitivity to Mifepristone and IMN.

3.Contraindications to Mifepristone and IMN.

4.Those not giving consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in Bishops Score <br/ ><br>Duration between administration of cervical ripening agents and delivery <br/ ><br>Failed induction is after 2 doses of misoprostol 3hrs apart <br/ ><br>Timepoint: at baseline <br/ ><br>after 6hrs <br/ ><br>after 12hrs <br/ ><br>at 15 hrs <br/ ><br>at 18 hrs
Secondary Outcome Measures
NameTimeMethod
Mode of deliveryTimepoint: Failed induction is after 2 doses of misoprostol 3h apart
© Copyright 2025. All Rights Reserved by MedPath